Back to results
US 12,723,041 B2Granted
Lactone and lactam containing compounds useful as immunomodulators
AssigneeBristol-Myers Squibb Company
InventorsTao Wang, Zhongxing Zhang, Zhiwei Yin
Life of this patent
Estimating the term…
Abstract
The present disclosure generally relates to lactone and lactam containing compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.
Claims14
A compound of Formula (I):
- or a pharmaceutically acceptable salt thereof, wherein:
- R1 is independently —(O)m—(CH2)n—R1a or —(CH2)n—(O)m—R1b,
- R1a is independently a 5- to 6-membered heterocycle with one to two heteroatoms selected from O, N, S, and NRa;
- wherein said heterocycle is substituted with 0 to 3 Rb;
- R1b is phenyl or a 5- to 6-membered heteroaryl with one to four heteroatoms selected from O, N, S, and NRa;
- wherein said phenyl and heteroaryl are substituted with 0 to 3 R1c;
- R1c is independently halogen, CN, OH, SH, NH2, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkyl substituted with 0 to 1 OH, or C3-C6 cycloalkyl, —(O)m—(CH2)n—R1d, or —(CH2)n—NR7—R2a;
- R1d is phenyl or a 5- to 6-membered heteroaryl with one to four heteroatoms selected from O, N, S, and NRa, wherein said phenyl and heteroaryl are substituted with 0 to 3 Rd;
- Z is a bond or a C1-C2 alkylene;
- R2 is independently a 4- to 8-membered lactone or lactam substituted with 0 to 4 Rc;
- R3, R4 and R5 are, at each occurrence, independently halogen, CN, OH, SH, NH2, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, or C3-C6 cycloalkyl;
- R6 is independently hydrogen, C1-C4 alkyl, or —(CH2)n—R6a;
- R6a is independently phenyl or a 5- to 6-membered heteroaryl with one to four heteroatoms selected from O, N, S, and NRa;
- wherein said phenyl and heteroaryl are substituted with 0 to 3 R6b;
- R6b is independently halogen, CN, OH, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, or C1-C4 haloalkoxy;
- R7 is independently hydrogen, C1-C4 alkyl, —C(O)C1-C4 alkyl, —(CH2)n—C3-C6 cycloalkyl, or —(CH2)n-phenyl;
- alternatively, R6 and R7 can be joined to form W;
- and
- W is a 1 to 4 membered linker with elements independently selected from carbon, oxygen, and nitrogen;
- wherein said linker is substituted with 0 to 2 Re;
- Ra is independently halogen, C1-C4 alkyl, —(CH2)n—C3-C6 cycloalkyl, or —(CH2)n-phenyl;
- Rb and Rc are, at each occurrence, independently oxo, halogen, CN, OH, C1-C4 alkyl, or C1-C4 alkoxy;
- Rd is, at each occurrence, independently halogen, CN, OH, C1-C4 alkyl, or C1-C4 alkoxy;
- Re is independently oxo, —CH2, halogen, CN, OH, C1-C4 alkyl, or C1-C4 alkoxy;
- m is, at each occurrence, independently 0 or 1;
- n is, at each occurrence, independently 0, 1, or 2;
- r, s, and t are each independently 0, 1, or 2.
24 more elements
A compound selected from:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.